$XOMA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in XOMA Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in XOMA Corp. Get notifications about new insider transactions in XOMA Corp for free.
Page: < prev 1 2 3 4 5 6 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 16 2018 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Option Exercise | M | 11.20 | 3,026 | 33,891 | 0 | |
Nov 16 2018 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Option Exercise | M | 4.03 | 4,667 | 18,808 | 3,333 | |
Nov 16 2018 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Sell | S | 12.67 | 5,528 | 70,040 | 9,144 | 14.7 K to 9.1 K (-37.68 %) |
Nov 16 2018 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Buy | M | 11.20 | 3,026 | 33,891 | 14,672 | 11.6 K to 14.7 K (+25.98 %) |
Nov 16 2018 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Buy | M | 4.03 | 4,667 | 18,808 | 11,646 | 7 K to 11.6 K (+66.87 %) |
Nov 15 2018 | XOMA | XOMA Corp | Neal James R | CEO | Buy | P | 13.26 | 4,000 | 53,056 | 20,333 | 16.3 K to 20.3 K (+24.49 %) |
Jul 23 2018 | XOMA | XOMA Corp | DATTA DEEPSHIKHA | Chief Business Offi ... | Option Exercise | A | 25.05 | 24,000 | 601,200 | 24,000 | |
May 21 2018 | XOMA | XOMA Corp | LIMBER JOSEPH M | Director | Option Exercise | A | 25.16 | 5,052 | 127,108 | 5,052 | |
May 21 2018 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Option Exercise | A | 25.16 | 5,052 | 127,108 | 5,052 | |
May 21 2018 | XOMA | XOMA Corp | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 25.16 | 5,052 | 127,108 | 5,052 | |
May 21 2018 | XOMA | XOMA Corp | PERRY MATTHEW D | Director | Option Exercise | A | 25.16 | 5,052 | 127,108 | 5,052 | |
Apr 27 2018 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Option Exercise | M | 5.50 | 2,655 | 14,603 | 24,000 | |
Apr 27 2018 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Option Exercise | M | 5.50 | 8,345 | 45,898 | 26,655 | |
Apr 27 2018 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Sell | S | 24.77 | 2,655 | 65,757 | 6,555 | 9.2 K to 6.6 K (-28.83 %) |
Apr 27 2018 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Buy | M | 5.50 | 2,655 | 14,603 | 9,210 | 6.6 K to 9.2 K (+40.50 %) |
Apr 27 2018 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Sell | S | 24.69 | 8,345 | 206,050 | 6,555 | 14.9 K to 6.6 K (-56.01 %) |
Apr 27 2018 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Buy | M | 5.50 | 8,345 | 45,898 | 14,900 | 6.6 K to 14.9 K (+127.31 %) |
Apr 27 2018 | XOMA | XOMA Corp | Neal James R | CEO | Option Exercise | M | 5.50 | 15,655 | 86,103 | 76,000 | |
Apr 27 2018 | XOMA | XOMA Corp | Neal James R | CEO | Option Exercise | M | 5.50 | 8,345 | 45,898 | 91,655 | |
Apr 27 2018 | XOMA | XOMA Corp | Neal James R | CEO | Sell | S | 24.42 | 15,655 | 382,236 | 16,333 | 32 K to 16.3 K (-48.94 %) |
Apr 27 2018 | XOMA | XOMA Corp | Neal James R | CEO | Buy | M | 5.50 | 15,655 | 86,103 | 31,988 | 16.3 K to 32 K (+95.85 %) |
Apr 27 2018 | XOMA | XOMA Corp | Neal James R | CEO | Sell | S | 24.69 | 8,345 | 206,050 | 16,333 | 24.7 K to 16.3 K (-33.82 %) |
Apr 27 2018 | XOMA | XOMA Corp | Neal James R | CEO | Buy | M | 5.50 | 8,345 | 45,898 | 24,678 | 16.3 K to 24.7 K (+51.09 %) |
Mar 29 2018 | XOMA | XOMA Corp | DATTA DEEPSHIKHA | Chief Business Offi ... | Option Exercise | A | 33.41 | 80,000 | 2,672,800 | 80,000 | |
Feb 28 2018 | XOMA | XOMA Corp | LIMBER JOSEPH M | Director | Option Exercise | A | 19.40 | 2,366 | 45,900 | 2,366 | |
Feb 28 2018 | XOMA | XOMA Corp | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 19.40 | 2,366 | 45,900 | 2,366 | |
Feb 28 2018 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Option Exercise | A | 19.40 | 2,366 | 45,900 | 2,366 | |
Feb 16 2018 | XOMA | XOMA Corp | Neal James R | CEO | Option Exercise | A | 27.41 | 30,000 | 822,300 | 30,000 | |
Feb 16 2018 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Option Exercise | A | 27.41 | 25,000 | 685,250 | 25,000 | |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Option Exercise | M | 4.03 | 26,145 | 105,364 | 266,204 | |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Option Exercise | M | 4.03 | 8,583 | 34,589 | 292,349 | |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Option Exercise | M | 4.03 | 11,568 | 46,619 | 300,932 | |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Sell | S | 27.44 | 2,200 | 60,366 | 16,333 | 18.5 K to 16.3 K (-11.87 %) |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Sell | S | 27.00 | 23,945 | 646,400 | 18,533 | 42.5 K to 18.5 K (-56.37 %) |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Buy | M | 4.03 | 26,145 | 105,364 | 42,478 | 16.3 K to 42.5 K (+160.07 %) |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Sell | S | 30.45 | 600 | 18,270 | 16,333 | 16.9 K to 16.3 K (-3.54 %) |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Sell | S | 29.42 | 900 | 26,477 | 16,933 | 17.8 K to 16.9 K (-5.05 %) |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Sell | S | 29.05 | 3,564 | 103,532 | 17,833 | 21.4 K to 17.8 K (-16.66 %) |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Sell | S | 27.13 | 3,519 | 95,468 | 21,397 | 24.9 K to 21.4 K (-14.12 %) |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Buy | M | 4.03 | 8,583 | 34,589 | 24,916 | 16.3 K to 24.9 K (+52.55 %) |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Sell | S | 31.77 | 484 | 15,375 | 16,333 | 16.8 K to 16.3 K (-2.88 %) |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Sell | S | 30.79 | 11,084 | 341,300 | 16,817 | 27.9 K to 16.8 K (-39.73 %) |
Nov 15 2017 | XOMA | XOMA Corp | Neal James R | CEO | Buy | M | 4.03 | 11,568 | 46,619 | 27,901 | 16.3 K to 27.9 K (+70.83 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Option Exercise | M | 4.03 | 8,392 | 33,820 | 77,778 | |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Option Exercise | M | 4.03 | 6,847 | 27,593 | 86,170 | |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Option Exercise | M | 4.03 | 6,983 | 28,141 | 93,017 | |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Sell | S | 27.44 | 200 | 5,487 | 6,555 | 6.8 K to 6.6 K (-2.96 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Sell | S | 27.04 | 8,192 | 221,491 | 6,755 | 14.9 K to 6.8 K (-54.81 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Buy | M | 4.03 | 8,392 | 33,820 | 14,947 | 6.6 K to 14.9 K (+128.02 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Sell | S | 30.49 | 250 | 7,622 | 6,555 | 6.8 K to 6.6 K (-3.67 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Sell | S | 29.61 | 600 | 17,768 | 6,805 | 7.4 K to 6.8 K (-8.10 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Sell | S | 28.98 | 3,180 | 92,152 | 7,405 | 10.6 K to 7.4 K (-30.04 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Sell | S | 27.16 | 2,817 | 76,512 | 10,585 | 13.4 K to 10.6 K (-21.02 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Buy | M | 4.03 | 6,847 | 27,593 | 13,402 | 6.6 K to 13.4 K (+104.45 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Sell | S | 31.77 | 486 | 15,438 | 6,555 | 7 K to 6.6 K (-6.90 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Sell | S | 30.93 | 6,497 | 200,981 | 7,041 | 13.5 K to 7 K (-47.99 %) |
Nov 15 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | SVP, Finance & CFO | Buy | M | 4.03 | 6,983 | 28,141 | 13,538 | 6.6 K to 13.5 K (+106.53 %) |
May 22 2017 | XOMA | XOMA Corp | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 4.03 | 8,000 | 32,240 | 8,000 | |
May 22 2017 | XOMA | XOMA Corp | Walbert Timothy P | Director | Option Exercise | A | 4.03 | 8,000 | 32,240 | 8,000 | |
May 22 2017 | XOMA | XOMA Corp | Varian John | Director | Option Exercise | A | 4.03 | 8,000 | 32,240 | 8,000 | |
May 22 2017 | XOMA | XOMA Corp | LIMBER JOSEPH M | Director | Option Exercise | A | 4.03 | 8,000 | 32,240 | 8,000 | |
May 22 2017 | XOMA | XOMA Corp | HUTT PETER BARTON | Director | Option Exercise | A | 4.03 | 8,000 | 32,240 | 8,000 | |
May 22 2017 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Option Exercise | A | 4.03 | 8,000 | 32,240 | 8,000 | |
May 22 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | VP, Finance & CFO | Option Exercise | A | 4.03 | 100,000 | 403,000 | 100,000 | |
May 22 2017 | XOMA | XOMA Corp | Neal James R | CEO | Option Exercise | A | 4.03 | 312,500 | 1,259,375 | 312,500 | |
May 18 2017 | XOMA | XOMA Corp | Varian John | Director | Sell | S | 6.24 | 39,540 | 246,919 | 2,344 | 41.9 K to 2.3 K (-94.40 %) |
Mar 23 2017 | XOMA | XOMA Corp | Neal James R | VP Business Develop ... | Sell | S | 5.40 | 5,105 | 27,569 | 15,366 | 20.5 K to 15.4 K (-24.94 %) |
Mar 23 2017 | XOMA | XOMA Corp | BURNS THOMAS M. | VP, Finance & Chief ... | Sell | S | 5.40 | 2,598 | 14,030 | 6,555 | 9.2 K to 6.6 K (-28.38 %) |
Mar 07 2017 | XOMA | XOMA Corp | PERRY MATTHEW D | Director | Option Exercise | A | 4.67 | 15,222 | 71,087 | 15,222 | |
Mar 07 2017 | XOMA | XOMA Corp | PERRY MATTHEW D | Director | Grant | A | 0.00 | 11,799 | 0 | 11,799 | 0 to 11.8 K |
Feb 01 2017 | XOMA | XOMA Corp | Neal James R | VP Business Develop ... | Sell | S | 4.50 | 95 | 428 | 20,471 | 20.6 K to 20.5 K (-0.46 %) |
Feb 01 2017 | XOMA | XOMA Corp | Neal James R | VP Business Develop ... | Sell | S | 4.53 | 100 | 453 | 20,566 | 20.7 K to 20.6 K (-0.48 %) |
Jan 10 2017 | XOMA | XOMA Corp | Neal James R | VP Business Develop ... | Sell | S | 5.15 | 125 | 644 | 20,666 | 20.8 K to 20.7 K (-0.60 %) |
Dec 23 2016 | XOMA | XOMA Corp | Varian John | Director | Sell | S | 5.75 | 13,549 | 77,907 | 41,884 | 55.4 K to 41.9 K (-24.44 %) |
Dec 23 2016 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sell | S | 5.75 | 3,230 | 18,573 | 8,217 | 11.4 K to 8.2 K (-28.22 %) |
Dec 23 2016 | XOMA | XOMA Corp | BURNS THOMAS M. | VP, Finance & Chief ... | Option Exercise | A | 5.50 | 35,000 | 192,500 | 35,000 | |
Dec 23 2016 | XOMA | XOMA Corp | Neal James R | VP Business Develop ... | Option Exercise | A | 5.50 | 100,000 | 550,000 | 100,000 | |
Nov 03 2016 | XOMA | XOMA Corp | Neal James R | VP Business Develop ... | Sell | S | 5.25 | 150 | 788 | 20,541 | 20.7 K to 20.5 K (-0.72 %) |
Oct 11 2016 | XOMA | XOMA Corp | Neal James R | VP Business Develop ... | Sell | S | 0.45 | 2,500 | 1,120 | 413,839 | 416.3 K to 413.8 K (-0.60 %) |
Aug 02 2016 | XOMA | XOMA Corp | Walbert Timothy P | Director | Option Exercise | A | 0.56 | 60,532 | 33,892 | 60,532 | |
Aug 02 2016 | XOMA | XOMA Corp | Walbert Timothy P | Director | Grant | A | 0.00 | 48,246 | 0 | 129,314 | 81.1 K to 129.3 K (+59.51 %) |
Aug 02 2016 | XOMA | XOMA Corp | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 0.56 | 60,532 | 33,892 | 60,532 | |
Aug 02 2016 | XOMA | XOMA Corp | WYSZOMIERSKI JACK L | Director | Grant | A | 0.00 | 48,246 | 0 | 129,314 | 81.1 K to 129.3 K (+59.51 %) |
Aug 02 2016 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Option Exercise | A | 0.56 | 60,532 | 33,892 | 60,532 | |
Aug 02 2016 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Grant | A | 0.00 | 48,246 | 0 | 139,596 | 91.4 K to 139.6 K (+52.81 %) |
Aug 02 2016 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Option Exercise | A | 0.56 | 60,532 | 33,892 | 60,532 | |
Aug 02 2016 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Grant | A | 0.00 | 48,246 | 0 | 139,596 | 91.4 K to 139.6 K (+52.81 %) |
Aug 02 2016 | XOMA | XOMA Corp | LIMBER JOSEPH M | Director | Option Exercise | A | 0.56 | 60,532 | 33,892 | 60,532 | |
Aug 02 2016 | XOMA | XOMA Corp | LIMBER JOSEPH M | Director | Grant | A | 0.00 | 48,246 | 0 | 124,219 | 76 K to 124.2 K (+63.50 %) |
Aug 02 2016 | XOMA | XOMA Corp | HUTT PETER BARTON | Director | Option Exercise | A | 0.56 | 121,064 | 67,784 | 121,064 | |
May 31 2016 | XOMA | XOMA Corp | WYSZOMIERSKI JACK L | Director | Option Exercise | M | 0.00 | 2,800 | 0 | 0 | |
May 31 2016 | XOMA | XOMA Corp | WYSZOMIERSKI JACK L | Director | Buy | M | 0.00 | 2,800 | 0 | 81,068 | 78.3 K to 81.1 K (+3.58 %) |
May 31 2016 | XOMA | XOMA Corp | Walbert Timothy P | Director | Option Exercise | M | 0.00 | 2,800 | 0 | 0 | |
May 31 2016 | XOMA | XOMA Corp | Walbert Timothy P | Director | Buy | M | 0.00 | 2,800 | 0 | 81,068 | 78.3 K to 81.1 K (+3.58 %) |
May 31 2016 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Option Exercise | M | 0.00 | 3,150 | 0 | 0 | |
May 31 2016 | XOMA | XOMA Corp | VAN NESS W DENMAN | Director | Buy | M | 0.00 | 3,150 | 0 | 91,350 | 88.2 K to 91.4 K (+3.57 %) |
May 31 2016 | XOMA | XOMA Corp | LIMBER JOSEPH M | Director | Option Exercise | M | 0.00 | 2,800 | 0 | 0 | |
May 31 2016 | XOMA | XOMA Corp | LIMBER JOSEPH M | Director | Buy | M | 0.00 | 2,800 | 0 | 75,973 | 73.2 K to 76 K (+3.83 %) |
Mar 22 2016 | XOMA | XOMA Corp | BURNS THOMAS M. | VP, Finance & Chief ... | Sell | S | 0.78 | 19,249 | 15,105 | 183,071 | 202.3 K to 183.1 K (-9.51 %) |
Mar 22 2016 | XOMA | XOMA Corp | Neal James R | VP Business Develop ... | Sell | S | 0.78 | 19,813 | 15,547 | 411,339 | 431.2 K to 411.3 K (-4.60 %) |
Mar 22 2016 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 0.00 | 12,141 | 0 | 0 | |
Mar 22 2016 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 0.78 | 24,194 | 18,985 | 326,601 | 350.8 K to 326.6 K (-6.90 %) |
Mar 22 2016 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 0.00 | 12,141 | 0 | 350,795 | 338.7 K to 350.8 K (+3.59 %) |
Mar 22 2016 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
Mar 22 2016 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sell | S | 0.78 | 14,785 | 11,602 | 228,942 | 243.7 K to 228.9 K (-6.07 %) |
Mar 22 2016 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Buy | M | 0.00 | 9,500 | 0 | 243,727 | 234.2 K to 243.7 K (+4.06 %) |
Mar 22 2016 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 0.00 | 36,907 | 0 | 0 | |
Mar 22 2016 | XOMA | XOMA Corp | Varian John | CEO | Sell | S | 0.78 | 81,022 | 63,578 | 1,108,673 | 1.2 M to 1.1 M (-6.81 %) |
Mar 22 2016 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 0.00 | 36,907 | 0 | 1,189,695 | 1.2 M to 1.2 M (+3.20 %) |
Feb 29 2016 | XOMA | XOMA Corp | Varian John | CEO | Grant | A | 0.00 | 541,600 | 0 | 1,152,788 | 611.2 K to 1.2 M (+88.61 %) |
Feb 29 2016 | XOMA | XOMA Corp | Neal James R | Grant | A | 0.00 | 248,954 | 0 | 431,152 | 182.2 K to 431.2 K (+136.64 %) | |
Feb 29 2016 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Grant | A | 0.00 | 198,330 | 0 | 338,654 | 140.3 K to 338.7 K (+141.34 %) |
Feb 29 2016 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Grant | A | 0.00 | 140,000 | 0 | 234,227 | 94.2 K to 234.2 K (+148.58 %) |
Feb 29 2016 | XOMA | XOMA Corp | BURNS THOMAS M. | VP, Finance & Chief ... | Grant | A | 0.00 | 108,560 | 0 | 202,320 | 93.8 K to 202.3 K (+115.78 %) |
Feb 03 2016 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sell | S | 1.01 | 8,000 | 8,080 | 94,227 | 102.2 K to 94.2 K (-7.83 %) |
Dec 30 2015 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sell | S | 1.37 | 8,000 | 10,937 | 102,227 | 110.2 K to 102.2 K (-7.26 %) |
Dec 15 2015 | XOMA | XOMA Corp | LIMBER JOSEPH M | Director | Option Exercise | M | 0.00 | 5,600 | 0 | 0 | |
Dec 15 2015 | XOMA | XOMA Corp | LIMBER JOSEPH M | Director | Buy | M | 0.00 | 5,600 | 0 | 73,173 | 67.6 K to 73.2 K (+8.29 %) |
Nov 25 2015 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sell | S | 1.35 | 8,000 | 10,800 | 110,227 | 118.2 K to 110.2 K (-6.77 %) |
Oct 28 2015 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sell | S | 1.04 | 8,000 | 8,358 | 118,227 | 126.2 K to 118.2 K (-6.34 %) |
Aug 18 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 0.00 | 94,573 | 0 | 195,239 | |
Aug 18 2015 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 0.00 | 94,573 | 0 | 611,188 | 516.6 K to 611.2 K (+18.31 %) |
Aug 18 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | D | 0.83 | 35,799 | 29,838 | 516,615 | 552.4 K to 516.6 K (-6.48 %) |
Aug 18 2015 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Option Exercise | M | 0.00 | 16,264 | 0 | 38,917 | |
Aug 18 2015 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Buy | M | 0.00 | 16,264 | 0 | 126,227 | 110 K to 126.2 K (+14.79 %) |
Aug 18 2015 | XOMA | XOMA Corp | SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sell | D | 0.83 | 6,157 | 5,132 | 109,963 | 116.1 K to 110 K (-5.30 %) |
Aug 18 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 0.00 | 26,748 | 0 | 0 | |
Aug 18 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | D | 0.83 | 10,801 | 9,003 | 138,292 | 149.1 K to 138.3 K (-7.24 %) |
Aug 18 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 0.00 | 26,748 | 0 | 149,093 | 122.3 K to 149.1 K (+21.86 %) |
Aug 18 2015 | XOMA | XOMA Corp | Neal James R | Sell | D | 0.83 | 9,067 | 7,557 | 175,402 | 184.5 K to 175.4 K (-4.92 %) | |
Jul 23 2015 | XOMA | XOMA Corp | BAKER BROS. ADVISORS LP | Sell | S | 1.09 | 229,436 | 250,659 | 90,538 | 320 K to 90.5 K (-71.70 %) | |
Jul 23 2015 | XOMA | XOMA Corp | BAKER BROS. ADVISORS LP | Sell | S | 1.09 | 9,411,311 | 10,281,857 | 3,153,539 | 12.6 M to 3.2 M (-74.90 %) | |
Jul 23 2015 | XOMA | XOMA Corp | BAKER BROS. ADVISORS LP | Sell | S | 1.09 | 1,359,253 | 1,484,984 | 467,436 | 1.8 M to 467.4 K (-74.41 %) | |
Jul 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 1.24 | 10,000 | 12,400 | 70,392 | |
Jul 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | S | 4.49 | 10,000 | 44,869 | 552,414 | 562.4 K to 552.4 K (-1.78 %) |
Jul 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 1.24 | 10,000 | 12,400 | 562,414 | 552.4 K to 562.4 K (+1.81 %) |
Jul 17 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 5,000 | 15,200 | 27,040 | |
Jul 17 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.60 | 5,000 | 22,992 | 122,345 | 127.3 K to 122.3 K (-3.93 %) |
Jul 17 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 5,000 | 15,200 | 127,345 | 122.3 K to 127.3 K (+4.09 %) |
Jul 10 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 29,000 | 88,160 | 32,040 | |
Jul 10 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Option Exercise | M | 3.04 | 4,400 | 13,376 | 61,040 | |
Jul 10 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.55 | 29,000 | 131,985 | 122,345 | 151.3 K to 122.3 K (-19.16 %) |
Jul 10 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 29,000 | 88,160 | 151,345 | 122.3 K to 151.3 K (+23.70 %) |
Jul 10 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Sell | S | 4.55 | 4,400 | 20,020 | 122,345 | 126.7 K to 122.3 K (-3.47 %) |
Jul 10 2015 | XOMA | XOMA Corp | RUBIN PAUL D | Sr. VP Clinical Dev ... | Buy | M | 3.04 | 4,400 | 13,376 | 126,745 | 122.3 K to 126.7 K (+3.60 %) |
Jun 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Option Exercise | M | 1.24 | 10,000 | 12,400 | 80,392 | |
Jun 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Sell | S | 3.64 | 10,000 | 36,362 | 552,414 | 562.4 K to 552.4 K (-1.78 %) |
Jun 17 2015 | XOMA | XOMA Corp | Varian John | CEO | Buy | M | 1.24 | 10,000 | 12,400 | 562,414 | 552.4 K to 562.4 K (+1.81 %) |
Jun 01 2015 | XOMA | XOMA Corp | BOWES WILLIAM K JR | Director | Option Exercise | M | 0.00 | 2,800 | 0 | 2,800 | |
Jun 01 2015 | XOMA | XOMA Corp | BOWES WILLIAM K JR | Director | Option Exercise | M | 0.00 | 2,800 | 0 | 0 |